Business

Rajratan Global Consolidated December 2025 Net Sales at Rs 301.53 crore, up 38.09% Y-o-Y

Tata Comm Consolidated December 2025 Net Sales at Rs 6,188.97 crore, up 6.74% Y-o-Y

Mastek Consolidated December 2025 Net Sales at Rs 905.68 crore, up 4.16% Y-o-Y

Dr Reddys Labs Consolidated December 2025 Net Sales at Rs 8,753.40 crore, up 4.44% Y-o-Y

Bajaj Consumer Consolidated December 2025 Net Sales at Rs 306.09 crore, up 30.58% Y-o-Y

Tatva Chintan Consolidated December 2025 Net Sales at Rs 131.33 crore, up 52.9% Y-o-Y

Supreme Ind Consolidated December 2025 Net Sales at Rs 2,686.94 crore, up 7.05% Y-o-Y

HINDPETRO Consolidated December 2025 Net Sales at Rs 115,153.20 crore, up 4.11% Y-o-Y

Chembond Chem Consolidated December 2025 Net Sales at Rs 86.35 crore, up 15.31% Y-o-Y

Waaree Energies Consolidated December 2025 Net Sales at Rs 7,565.05 crore, up 118.81% Y-o-Y

KPIGREEN Consolidated December 2025 Net Sales at Rs 662.86 crore, up 44.62% Y-o-Y

Eternal Consolidated December 2025 Net Sales at Rs 16,315.00 crore, up 201.85% Y-o-Y

Gravita India Consolidated December 2025 Net Sales at Rs 1,017.07 crore, up 2.07% Y-o-Y

Refex Ind Consolidated December 2025 Net Sales at Rs 576.01 crore, down 19.68% Y-o-Y

Shilp Gravures Consolidated December 2025 Net Sales at Rs 23.21 crore, up 8.05% Y-o-Y

Sangam India Consolidated December 2025 Net Sales at Rs 774.66 crore, up 2.74% Y-o-Y

Vardhman Text Consolidated December 2025 Net Sales at Rs 2,505.31 crore, up 1.62% Y-o-Y

Jindal Stainles Consolidated December 2025 Net Sales at Rs 10,517.55 crore, up 6.16% Y-o-Y

Goldman Sachs raises 2026-end gold price forecast by $500 to $5,400/oz

The safe‑haven metal has climbed more than 11% so far in 2026.

Q3 results impact: Bajaj Consumer shares hit 20% upper circuit on strong earnings, OFSS rises 3%; KEI Industries declines

Bajaj Consumer Care shares surged after the company posted an 83 percent jump in consolidated net profit to Rs 46.37 crore for the December quarter of FY26.

Zydus launches Opdivo biosimilar in India, will help cut cancer treatment cost

Nivolumab, launched at one-fourth the price of the original drug, is one of the most widely inhibitors used in treating various cancer types including lung, melanoma, kidney and Hodgkin lymphoma

Accumulate Supreme Industries; target of Rs 4566: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Supreme Industries has recommended buy rating on the stock with a target price of Rs 4566 in its research report dated January 21, 2026.

Eternal shares tumble 9% from day's high with management transition in focus, brokerages' concerns over competition

Motilal sees the risk of Eternal being drawn into a 'dogfight', with lower minimum order values and higher discounts amid intensifying competition.

Government readies wider decriminalisation push beyond Jan Vishwas II

Around 350 provisions across 33 ministries identified for decriminalisation; exercise may be folded into Jan Vishwas II or rolled out as a separate Bill

Massive 370 percent return! SGB 2018–19 Series V turns Rs 1 lakh investment into Rs 4.6 lakh; check redemption price by RBI

Sovereign Gold Bonds are issued by the Government of India and managed by the RBI, offering investors exposure to gold without holding physical metal.